News

Biopsy can differentiate risk level for patients, but selectively indicated

Transient topical corticosteroids could take edge off severe irritation from topical retinoid acne treatment without decreasing efficacy.

Striking the perfect balance for retinoid use isn't easy. In this article, Dr. Michael Kolodney outlines his techniques for applying and managing retinoids.

Factors that drive lip squamous cell carcinomas in men.

Men are increasingly seeking aesthetic procedures, but they tend to learn toward specific procedures more than others. Learn more in our table-of-the-month.

While there is an increasing interest among men in cosmetic procedures, there is little research in this area to guide physicians. Experts say that customization is best for tough cases.

Dr. Norman Levine offers bits of advice for those considering this type of change in your practice for those considering selling their practices to venture capital-backed enterprises based on his experience with one such company.

Dr. Ad employs a variety of advertising methods to grow his practice. Two years ago, he ran an ad that said prolonged use of his $1,000/tube facial cream would negate a need for a facelift. Now he is facing a complaint by a patient who bought 20 tubes and saw no improvement over the course of a year. Dr. Ad claims that his marketing was harmless and no different than most other ads. Is he in trouble?

Structure and frequency in the performance review process can create effective two-way discussions. Point out plenty of positives to keep the employee at ease during the review.

Three tactics to set your employees at ease and to facilitate effective two-way discussions.

A round-up of the latest products hitting the dermatology market including treatment for eczema and wounds, plus care for rejuvenating procedures.

A known oncogene previously associated with carcinomas of the breast, liver, ovaries, and colon appears to suppress the growth of melanoma cells, a team of researchers reported recently in Cell Reports.

Treatment for atopic dermatitis isn’t always straightforward. In this article, a physician outlines treatment approaches.

In this article, we take a look at the development of new treatments for atopic dermatitis.

Formulated with natural ingredients, emerginC’s vitamin C line, diminishes dark spots, brightens, and repairs sun-damaged skin.

Tattoos alter the skin’s ability to produce sweat and result in higher concentrations of sodium, a study shows.

“Because atopic dermatitis is episodic, its incidence, prevalence, persistence, remission, flare and long-term control require careful definition,” researchers write.

Almost seven in 10 consumers surveyed recently expressed interest in undergoing a cosmetic procedure, which is twice as many who considered such treatments in 2013, according to findings released by the American Society for Dermatologic Surgery (ASDS).

New recommendations from the International Eczema Council aim to address a question that has gone largely unanswered: When should dermatologists and others prescribe systemic therapy to treat atopic dermatitis?

The IL-23 inhibitor risankizumab was superior to ustekinumab in a phase two trial of adult patients with moderate-to-severe chronic plaque psoriasis, researchers report. (©FreeBirdPhotos/Shutterstock.com)

New research offers strong evidence that vascular inflammation and risk of having a major adverse cardiovascular event increases with psoriasis duration.

The U.S. Food and Drug Administration granted an expanded FDA 510(k) clearance in September for Cynosure’s non-invasive body contouring product, SculpSure.

The American Academy of Dermatology (AAD) is assisting with the Merit-based Incentive Payment System (MIPS) by offering a series of tools that guide users based on customized input.

Neither smart technology like digital pill caps, nor financial incentives, significantly improved patients’ medication adherence, a study shows.

Kyocera Communication Systems, a subsidiary of Kyocera, is teaming with the University of Tsukuba to created artificial intelligence (AI)-based technology that could identify skin cancers and other skin diseases.

Innovative Skincare has recently launched several new products to exfoliate, refresh, and rehydrate skin.

All teachers and mentors instruct; great ones inspire. They find ways to connect, challenge, compel and convince, motivating students to reach goals and make a difference.In their own words, five dermatologists share their appreciation for teachers and mentors who made a lasting impression.

Early trial results show a significant reduction of itch with the oral NK-1 antagonist serlopitant

Dupilumab plus topical corticosteroids safe and effective after failure of cyclosporine in moderate-to-severe atopic dermatitis

Oral propranolol is prescribed for the most serious cases. In this Lancet review, experts highlight some considerations for treatment.